Brief: Royalty Pharma On June 3, Entered Into Underwriting Deal, Co To Issue & Sell To Underwriters $500 Mln Amount Of 5.150% Senior Notes Due 2029
04/06/2024 22:09
June 4 (Reuters) - Royalty Pharma PLC RPRX.O :
* ROYALTY PHARMA-ON JUNE 3,ENTERED INTO UNDERWRITING DEAL,
CO TO
ISSUE & SELL TO UNDERWRITERS $500 MILLION AMOUNT OF ITS 5.150%
SENIOR NOTES DUE 2029
* ROYALTY PHARMA:TO ISSUE, SELL TO UNDERWRITERS $500 MILLION
OF
ITS 5.400% SENIOR NOTES DUE 2034 & $500 MILLION OF ITS 5.900%
SENIOR NOTES DUE 2059 IN OFFERING
Source text for Eikon: ID:n0001193125-24-154347
Further company coverage: RPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)